Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3
Status:
Completed
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
This study will determine the renoprotective effect of febuxostat in prevention of contrast
induced acute kidney injury in chronic kidney disease patients Stage 3 undergoing
percutaneous coronary intervention.